Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer.

Secrist K, Kumar P, Wang MZ, Saleh-Birdjandi S, Salave S, Kumru OS, Mberkadji NS, Sakho F, Joshi SB, Volkin DB

Open source

DOI
10.3390/vaccines14100900
Published
2026 Oct 14
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14100900,
  title = {Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer.},
  author = {Secrist K and Kumar P and Wang MZ and Saleh-Birdjandi S and Salave S and Kumru OS and Mberkadji NS and Sakho F and Joshi SB and Volkin DB},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14100900},
  url = {https://doi.org/10.3390/vaccines14100900}
}

RIS

TY  - JOUR
TI  - Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer.
AU  - Secrist K
AU  - Kumar P
AU  - Wang MZ
AU  - Saleh-Birdjandi S
AU  - Salave S
AU  - Kumru OS
AU  - Mberkadji NS
AU  - Sakho F
AU  - Joshi SB
AU  - Volkin DB
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14100900
UR  - https://doi.org/10.3390/vaccines14100900
ER  - 

APA

K, S., P, K., MZ, W., S, S., S, S., OS, K., NS, M., F, S., SB, J., & DB, V. (2026). Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer.. Vaccines. https://doi.org/10.3390/vaccines14100900

Source records